Medmain Speaks

~Official Blog~

Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play

Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play

Posted by Maya Friday, May 9, 2025

Announcement of Participation in the Japan Night – 43rd Annual J.P. Morgan Healthcare Conference

We will participate in the Japan Night – 43rd Annual J.P. Morgan Healthcare Conference!

Posted by Maya Friday, January 10, 2025

Medmain Acquires ISO/IEC 27001 Certification for an Information Security Management System

Medmain Acquires ISO/IEC 27001 Certification for an Information Security Management System!

Posted by Maya Wednesday, January 8, 2025

Our CEO Osamu Iizuka had a presentation at Korea-Japan Startup Founder’s Day!

Our CEO Osamu Iizuka had a presentation at Korea-Japan Startup Founder’s Day!

Posted by Maya Friday, December 20, 2024

Our CEO Osamu Iizuka will have a presentation at Korea-Japan Startup Founder’s Day!

Our CEO Osamu Iizuka will have a presentation at Korea-Japan Startup Founder’s Day!

Posted by Maya Wednesday, November 13, 2024

FEATURED TAGS
news pathology people & culture pidport
ABOUT US
about us

Medmain is a health tech start up which is developing and providing "PidPort," a marketplace for pathological image diagnosis, which includes Deep Learning driven immediate pathological analysis. In this company blog "Medmain Speaks", we would like to write and post articles about our news, people/culture and pathology-focused columns.